**Core Concept**
Succinylcholine is a depolarizing neuromuscular blocking agent that acts by activating all nicotinic receptors on the muscle endplate, leading to sustained depolarization and muscle paralysis. Resistance to succinylcholine can occur due to various factors that alter the normal functioning of these receptors.

**Why the Correct Answer is Right**
Diseases that show resistance to succinylcholine typically involve mutations or alterations in the nicotinic acetylcholine receptor (nAChR) subunits. One such condition is **Malignant Hyperthermia (MH)**. MH is a genetic disorder caused by mutations in the RYR1 gene, which codes for the ryanodine receptor 1. Although MH is primarily associated with volatile anesthetics and succinylcholine, it can also lead to resistance to succinylcholine due to the abnormal functioning of the nAChR. Another condition is **Burns**, where the repeated exposure to heat and oxidative stress can alter the structure and function of the nAChR, leading to resistance to succinylcholine.

**Why Each Wrong Option is Incorrect**
**Option A:** Duchenne Muscular Dystrophy (DMD) is a genetic disorder that affects the dystrophin protein, which is essential for muscle function. While DMD patients may exhibit increased sensitivity to succinylcholine, they do not typically show resistance to it.

**Option B:** Myasthenia Gravis (MG) is an autoimmune disorder that affects the nicotinic acetylcholine receptors, leading to muscle weakness. However, MG patients may exhibit increased sensitivity to succinylcholine, not resistance.

**Option C:** Carcinomatosis refers to the spread of cancer to distant organs. While cancer patients may exhibit various drug interactions and sensitivities, carinomatosis is not typically associated with resistance to succinylcholine.

**Clinical Pearl / High-Yield Fact**
When administering succinylcholine, it is essential to consider the patient's medical history, particularly any history of burns, trauma, or malignant hyperthermia. A thorough pre-anesthetic evaluation and monitoring of the patient's response to the drug can help prevent adverse reactions.

**Correct Answer:** D. Malignant Hyperthermia